What is 1 Month Only Plan?
Answer
This is $85 plan , By choosing this plan, you agree to all aspects of the no-refund policy. The same policy that applies to our one-time yearly discount payment subscribers.
Signing up for the this subscription will give you access to all areas of site including the special FDA Calendar and Clinical Trials Update for one month only, You can renew it or choose another plan anytime from My Account -> My Subscription (My Account menu appears in top menu, only when you are logged in).
Signing up for the this subscription will give you access to all areas of site including the special FDA Calendar and Clinical Trials Update for one month only, You can renew it or choose another plan anytime from My Account -> My Subscription (My Account menu appears in top menu, only when you are logged in).
Category
about 11 hours ago
FDA panel votes against Xgeva; Nervous GlaxoSmithKline Pulls Cash Out of Eurozone: Below is a look at some of th... http://t.co/h6kQSAz6
about 1 day ago
Illumina’s Board Unanimously Rejects Roche’s Offer; Shire Announces FDA Approval of Vyvanse®: Below is a look at... http://t.co/L3FZivQV
about 1 day ago
Achillion ($ACHN) hammered after BofA rates to "Underperform" citing no M&A speculation. What we said last month: http://t.co/usWk95O6
about 2 days ago
Medgenics ($MDGN) up 10% on Monday! We first told you about the firm last Friday: http://t.co/aD50CMSH
about 2 days ago
Thinly traded BioLineRx shares move on hepatitis C deal: The shares of thinly traded BioLineRx (NASDAQ:BLRX) soa... http://t.co/ugbuZgNN
about 2 days ago
Orexigen® Announces Agreement From the FDA on a Special Protocol Assessment; Acorda Announces Launch of Generic ... http://t.co/vSt6VrLP
about 2 days ago
$CVM up 17% and technically looks like it may head higher.
about 2 days ago
$ANAC drops after GlaxoSmithKline (GSK) pauses enrollment for its clinical trials of its urinary tract infection drug. http://t.co/yUUSzkUr



